Publications by authors named "Andrew Furness"

Claim this Profile
T
Tumor-infiltrating lymphocyte therapy and the mucosal melanoma treatment landscape.
Jennifer Thomas, Max Julve, James Larkin, Andrew Furness

Cancer Commun (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal-fetal conflict and the timing of birth.
Andrew I Furness

Evol Med Public Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous toxicities in patients with metastatic uveal melanoma receiving tebentafusp: a retrospective review. The experience of a single large specialist institution.
Xingyue Maria Wang, Andrew Furness, Kara Heelan

Clin Exp Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercomparison of in-well, depth profile and online soil gas measurements for estimating petroleum natural source zone depletion rates: Will in-well gas samples suffice?
Greg B Davis, John L Rayner, Mike J Donn, Trevor P Bastow, Andrew Furness

J Hazard Mater· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letetresgene Autoleucel: A Milestone in Treatment of Myxoid/Round Cell Liposarcoma.
Emine Hatipoglu, Andrew J S Furness, Robin L Jones

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, Anne-Laure Cattin, Charlotte Spencer, Andrew J S Furness

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal.
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, Anne-Laure Cattin, Charlotte Spencer, Andrew J S Furness

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic data support phylogenetic congruence and reveal genomic changes associated with the repeated evolution of annualism in aplocheiloid killifishes (Cyprinodontiformes).
Andrew W Thompson, Amanda C Black, Yu Huang, Qiong Shi, Andrew I Furness

Mol Phylogenet Evol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Source Zone Depletion of crude oil, gasoline, diesel and aviation gasoline petroleum in the same soil/aquifer system - An intensive intercomparison field study and simulation.
John L Rayner, Mike J Donn, Greg B Davis, Trevor P Bastow, Kaveh Sookhak Lari, Andrew Furness

Sci Total Environ· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
Daniel Yiu, Silvia Aguilar-Duran, Charlotte Edwards, Dharmisha Chauhan, Andrew Furness

Br J Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifileucel: the first cellular therapy approved for solid tumours.
Max Julve, Mark P Lythgoe, James Larkin, Andrew J S Furness

Trends Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D d'Arienzo, Florentia Mina, Andrew J S Furness

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.
Carolin Ertl, Theresa Ruf, Dirk Mentzer, Mingzi Kong, Rafaela Kramer, Andrew J S Furness

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D d'Arienzo, Florentia Mina, Andrew J S Furness

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated independent origins of the placenta reveal convergent and divergent organ evolution within a single fish family (Poeciliidae).
Diego Safian, Marwa Ahmed, Henri van Kruistum, Andrew I Furness, David N Reznick

Sci Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids.
Simona Manacorda, Maria De Toro Carmena, Ciara Malone, Ha Mo Linh Le, Andrew J S Furness

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Lavinia Spain, Alexander Coulton, Irene Lobon, Andrew Rowan, Desiree Schnidrig, Andrew J S Furness

Cancer Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Mary Y Wu, Scott T C Shepherd, Annika Fendler, Edward J Carr, Lewis Au, Andrew J S Furness

Cancer Cell· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma.
Max Julve, Andrew Js Furness

Expert Opin Biol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'You give me fever!': are health services ready for immune cell engager therapy in advanced solid malignancies?
Claire Pettinger, Claire Livings, Rafael Grochot, Andrew Furness, Juanita Lopez

J Immunother Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric Whitman, Andrew J S Furness

J Immunother Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reproductive ecology drivers of egg attendance in amphibians.
Andrew I Furness, Isabella Capellini

Ecol Lett· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction.
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, John Baksi, Rajdeep Khattar, Andrew J S Furness

Cardiooncology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Andrew J S Furness

Cell Rep Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis.
James L Alexander, Hajir Ibraheim, Camellia Richards, Ben Shum, Polychronis Pavlidis, Andrew Furness

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis